Glaukos

Know your minimally invasive glaucoma surgery (MIGS) optionsMinimally invasive glaucoma surgery (MIGS) can help your patients with mild or moderate glaucoma. In order to recommend this treatment option, ODs must know what's available and which patients are good candidates. Barbara Fluder, OD, outlines the most common procedures.
How MIGS are changing glaucoma treatmentEvolving procedures continue to change the landscape of glaucoma treatments. Chief Optometric Editor Benjamin P. Casella, OD, FAAO, explores how the use of minimally (or micro-) invasive glaucoma surgery (MIGS) techniques can increase positive outcomes when treating glaucoma patients.
Glaucoma management can play important role with premium IOLs
Targeting dry eye in glaucoma patients
Targeting dry eye in glaucoma patientsA poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.
Growing number of devices set to transform glaucoma treatmentMinimally invasive glaucoma surgery (MIGS) is the latest development in the treatment of glaucoma. With two MIGS devices already approved in the United States, there are a variety of novel devices that have the potential to transform the treatment of glaucoma.
Evolution in glaucoma surgery mounting with MIGS proceduresAn expanding armamentarium of minimally invasive and micro-invasive glaucoma surgery procedures is transforming glaucoma management.
Glaucoma micro-stent’s 2-year data promisingTake-home: With the approval of a new surgical device aimed at lowering IOP, surgeons explore benefits of micro-stent implantation.
MIGS making big difference in glaucoma managementMicroinvasive glaucoma surgery devices already have transformed the management of glaucoma and will have a bigger impact in the future considering the options in the investigational pipeline and the opportunities they present.
A bullish view: Navigating beyond glaucoma company mistakesCompanies specializing in glaucoma products can make billions of dollars, but only if they can find a path through a minefield of scientific, regulatory, and marketing hazards, according to Richard A. Lewis, MD.
CPT coding for glaucoma surgery reporting undergoes changesGlaucoma specialists and general ophthalmologists alike must be aware of some significant procedure coding changes that will increase the complexity of the glaucoma surgical code set.